The study purpose is to gain a better understanding of the needs of adults aged 65 and older while they are receiving chemotherapy by measuring their resilience and tailor care plans based on their individual needs.
This is a prospective single-arm intervention trial of patients aged 65 or older with an active cancer diagnosis who are planned to receive chemotherapy and are eFI (Electronic Health Record (EHR)-based frailty index) pre-frail or frail. Patients will be enrolled before initiation of chemotherapy. Following a baseline assessment, subjects will be provided with results regarding their frailty, will be offered referrals for supportive care interventions and will participate in weekly symptom reporting (electronic survey + phone call from research nurse) for 12 weeks. Follow-up assessments will be completed at 12 weeks and a subset of participants and providers in participating clinics will be contacted to consent and participate in an interview to provide feedback on the intervention including barriers/facilitators.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
32
Geriatric assessment (GA) -guided supportive care and weekly Patient Reported Outcomes (PRO) symptom assessment
Levine Cancer Institute
Charlotte, North Carolina, United States
RECRUITINGAtrium Health Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, United States
RECRUITINGRecruitment rate
The proportion of patients who are enrolled out of the total number of eligible patients approached for enrollment
Time frame: Enrollment
Retention rate
The proportion of enrolled patient participants who complete Visit 2 out of the total number of patient participants who were enrolled and initiate chemotherapy
Time frame: At 12 weeks after initiation of standard of care chemotherapy
Completion rate of Weekly Symptom Assessment
The total number of weekly assessments completed out of the total number of weekly assessments among participants who enroll and initiate chemotherapy.
Time frame: Weeks 1 to 12
Number of Participants with Hospital admission
Number of participants with hospital admissions during the 12 weeks after chemotherapy initiation
Time frame: Baseline to Week 12
Number of Participants with ED visits
Number of participants with Emergency Department (ED) visits during the 12 weeks after chemotherapy initiation
Time frame: Baseline to Week 12
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.